Poulton Stuart

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Poulton Stuart's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-14
S Sale
63,663 +41.1%
110.76
US$2,715,759 		63,663 +41.1% 110.76 US$2,715,759
2026-03-03 2026-03-02
S Sale
80,775 -6.9%
353.74
US$1,892,274 		80,775 -6.9% 353.74 US$1,892,274
2026-02-19 2026-02-17
S Sale
91,453 +47.9%
174.50
US$3,511,473 		91,453 +47.9% 174.50 US$3,511,473
2025-09-16 2025-09-15
S Sale
401 -1.4%
6.43
US$2,578 		401 -1.4% 6.43 US$2,578
2025-03-06 2025-03-04
S Sale
3,548 -11.5%
6.29
US$22,317 		3,548 -11.5% 6.29 US$22,317
2025-02-19 2025-02-18
S Sale
5,914 -1.8%
0.63
US$3,726 		5,914 -1.8% 0.63 US$3,726
2024-07-31 2024-07-30
S Sale
2,883 -0.9%
1.06
US$3,056 		2,883 -0.9% 1.06 US$3,056
2024-03-04 2024-03-01
S Sale
6,155 -1.8%
1.20
US$7,386 		6,155 -1.8% 1.20 US$7,386
2024-03-04 2024-02-29
S Sale
16,311 -4.6%
1.17
US$19,084 		16,311 -4.6% 1.17 US$19,084
2024-02-20 2024-02-15
S Sale
99 -0.1%
1.40
US$139 		99 -0.1% 1.40 US$139
2024-02-20 2024-02-15
S Sale
5,748 -3.4%
1.33
US$7,645 		5,748 -3.4% 1.33 US$7,645
2023-08-01 2023-07-28
S Sale
2,845 -1.8%
1.70
US$4,836 		2,845 -1.8% 1.70 US$4,836
2023-02-17 2023-02-15
S Sale
196 -0.3%
3.16
US$619 		196 -0.3% 3.16 US$619
2023-02-17 2023-02-15
S Sale
8 -0.0%
3.23
US$26 		8 -0.0% 3.23 US$26
2023-02-17 2023-02-15
S Sale
5,665 -8.1%
3.19
US$18,071 		5,665 -8.1% 3.19 US$18,071